What did Advent International pay for RxBenefits?

Advent International acquired RxBenefits for $1.10B in 2021 (18.3x EBITDA), equivalent to 7.90x revenue. Target revenue was approximately $140.0M. Target EBITDA was approximately $60.0M.

What does RxBenefits do?

RxBenefits is a healthcare it business.

What multiple did Advent International pay for RxBenefits?

18.3x EBITDA and 7.90x revenue, based on disclosed deal value of $1.10B and disclosed financials.

M&A TRANSACTION · 2021

RxBenefits acquired by Advent International

$1.10B· 18.3x EBITDA· 7.90x revenue

Target

RxBenefits

Acquirer

Advent International

Private Equity buyer

Disclosed financials at time of acquisition

Revenue

$140.0M

EBITDA

$60.0M

Deal Value

$1.10B

EV/EBITDA

18.3x

Context

This $1.10B acquisition of RxBenefits by Advent International sits in the healthcare it sub-vertical. The 18.3x EBITDA multiple paid in 2021 can be compared against the population median for healthcare it transactions of similar size on our Healthcare It valuation hub. Advent International is acquiring as a private equity buyer; see how PE acquirers typically price healthcare it businesses on our Healthcare It PE buyer-pool page.

Source

Data sourced from Press releases, press reporting, and bond market research. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own healthcare it

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the RxBenefits acquisition.

Citation: ExitValue.ai. (2021). RxBenefits acquired by Advent International. https://exitvalue.ai/deals/rxbenefits-acquired-by-advent-international-hc-2021-0108